Successful use of recombinant factor VIIa for management of severe menorrhagia in an adolescent with an acquired inhibitor of human thrombin

Publisher： John Wiley & Sons Inc

E-ISSN： 1651-2227|93|6|841-843

ISSN： 0803-5253

Source： ACTA PAEDIATRICA, Vol.93, Iss.6, 2004-06, pp. : 841-843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation

By Gielen-Wijffels S.   Mook W.   Geest S.   Ramsay G.  

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1232-1234

Springer Publishing Company

Access to resources Recommend Favorite

The Evidence behind Inhibitor Treatment with Recombinant Factor VIIa

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 162-163

Karger

Access to resources Recommend Favorite

Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1787-1789

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Management of a Possible Antibiotic-Related Acquired Factor V Inhibitor: A Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 129, Iss. 3, 2012-12 ,pp. : 182-184

Karger

Access to resources Recommend Favorite